Unknown

Dataset Information

0

Downregulation of miRNA-146a-5p promotes malignant transformation of mesenchymal stromal/stem cells by glioma stem-like cells.


ABSTRACT: Mesenchymal stromal/stem cells (MSCs) are promising carriers in cell-based therapies against central nervous system diseases, and have been evaluated in various clinical trials in recent years. However, bone marrow-derived MSCs (BMSCs) are reportedly involved in tumorigenesis initiated by glioma stem-like cells (GSCs). We therefore established three different orthotopic models of GSC-MSC interactions in vivo using dual-color fluorescence tracing. Cell sorting and micropipetting techniques were used to obtain highly proliferative MSC monoclones from each model, and these cells were identified as transformed MSC lines 1, 2 and 3. Nineteen miRNAs were upregulated and 24 miRNAs were downregulated in all three transformed MSC lines compared to normal BMSCs. Reduced miR-146a-5p expression in the transformed MSCs was associated with their proliferation, malignant transformation and overexpression of heterogeneous nuclear ribonucleoprotein D. These findings suggest that downregulation of miR-146a-5p leads to overexpression of its target gene, heterogeneous nuclear ribonucleoprotein D, thereby promoting malignant transformation of MSCs during interactions with GSCs. Given the risk that MSCs will undergo malignant transformation in the glioma microenvironment, targeted glioma therapies employing MSCs as therapeutic carriers should be considered cautiously.

SUBMITTER: Dai X 

PROVIDER: S-EPMC7288935 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Downregulation of miRNA-146a-5p promotes malignant transformation of mesenchymal stromal/stem cells by glioma stem-like cells.

Dai Xingliang X   Wang Yunfei Y   Dong Xuchen X   Sheng Minfeng M   Wang Haiyang H   Shi Jia J   Sheng Yujing Y   Liu Liang L   Jiang Qianqian Q   Chen Yanming Y   Wu Bingshan B   Yang Xuejun X   Cheng Hongwei H   Kang Chunsheng C   Dong Jun J  

Aging 20200525 10


Mesenchymal stromal/stem cells (MSCs) are promising carriers in cell-based therapies against central nervous system diseases, and have been evaluated in various clinical trials in recent years. However, bone marrow-derived MSCs (BMSCs) are reportedly involved in tumorigenesis initiated by glioma stem-like cells (GSCs). We therefore established three different orthotopic models of GSC-MSC interactions <i>in vivo</i> using dual-color fluorescence tracing. Cell sorting and micropipetting techniques  ...[more]

Similar Datasets

| S-EPMC5732816 | biostudies-literature
| S-EPMC10401131 | biostudies-literature
| S-EPMC2731699 | biostudies-literature
| S-EPMC7926311 | biostudies-literature
| S-EPMC4304108 | biostudies-literature
| S-EPMC10563106 | biostudies-literature
| S-EPMC3719882 | biostudies-literature
| S-EPMC3589121 | biostudies-literature
| S-EPMC8505696 | biostudies-literature
| S-EPMC5522142 | biostudies-other